BiotechTube
Rivopharm

Rivopharm

Munich, Germany· Est.
rivopharm.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Rivopharm is a global generic pharmaceutical company headquartered in Switzerland, with a significant operational history dating back to its refocus in 1998. The company has expanded through strategic acquisitions and partnerships, establishing a presence across Europe and beyond with a broad portfolio of generic products. Its business model centers on developing, manufacturing, and marketing high-quality generic drugs, leveraging niche products and innovative formulation technologies to serve a wide range of therapeutic areas.

Generic Drugs

Technology Platform

Focus on innovative solutions in product formulation and delivery technologies for generic drugs, supported by cGMP manufacturing capabilities.

Funding History

1
Total raised:$10M
Series A$10M

Opportunities

Growth in the global generic drugs market driven by cost containment and patent expiries.
Expansion into new geographic markets through its associate network.
Potential for higher margins through niche and complex generic products.

Risk Factors

Intense price competition and margin pressure in the generic pharmaceutical industry.
Regulatory compliance risks across multiple jurisdictions.
Dependence on a broad portfolio subject to individual product price erosion and supply chain vulnerabilities.

Competitive Landscape

Operates in the highly competitive global generic pharmaceuticals market, competing against large multinational generics firms and local producers. Differentiates through Swiss quality standards, a niche portfolio strategy, and innovative formulation approaches. Faces pressure on pricing from healthcare payers and consolidating buyers.

More companies in Small Molecule Drugs →More companies in Germany →